These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27165313)

  • 1. Renal denervation with standard radiofrequency ablation catheter is effective in 24-hour ambulatory blood pressure reduction - follow-up at 1/3/6/12 months.
    Prochnau D; Otto S; Figulla HR; Surber R
    Neth Heart J; 2016 Jul; 24(7-8):449-55. PubMed ID: 27165313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal denervation with cryoenergy as second-line option is effective in the treatment of resistant hypertension in non-responders to radiofrequency ablation.
    Prochnau D; Heymel S; Otto S; Figulla HR; Surber R
    EuroIntervention; 2014 Sep; 10(5):640-5. PubMed ID: 25256203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal denervation for hypertension refractory to renal artery stenting.
    Bausback Y; Friedenberger J; Hertting K; Werner M; Branzan D; Freitas B; Piorkowski M; Schmidt A; Scheinert D
    J Endovasc Ther; 2014 Apr; 21(2):181-90. PubMed ID: 24754276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K; Rommel KP; Lapusca R; Blazek S; Besler C; Hartung P; von Roeder M; Kresoja KP; Desch S; Thiele H; Lurz P
    Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.
    Lauder L; Ewen S; Tzafriri AR; Edelman ER; Cremers B; Kulenthiran S; Ukena C; Linz D; Kindermann I; Tsioufis C; Scheller B; Böhm M; Mahfoud F
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):845-851. PubMed ID: 29555535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different ablation points of renal denervation on the efficacy of resistant hypertension.
    Zhang H; Li LY; Xiao RX; Zhang TC; Liu ZJ; Gao JQ
    PeerJ; 2020; 8():e9842. PubMed ID: 32983640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Open-label, Single-arm, Multicenter Feasibility Study Evaluating the Safety of Catheter-based Renal Denervation with DENEX™ in Patients with Uncontrolled Hypertension on Standard Medical Therapy.
    Kim CJ; Chang K; Kim BK; Park CG; Jang Y
    Korean Circ J; 2021 Jan; 51(1):43-55. PubMed ID: 33377328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension.
    Wang TD; Lee YH; Chang SS; Tung YC; Yeh CF; Lin YH; Pan CT; Hsu CY; Huang CY; Wu CK; Sung PH; Chiang LT; Wang YC; Tsai WC; Lin TT; Lin CP; Chen WJ; Hwang JJ
    Acta Cardiol Sin; 2019 May; 35(3):199-230. PubMed ID: 31249454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).
    Fengler K; Rommel KP; Blazek S; Besler C; Hartung P; von Roeder M; Petzold M; Winkler S; Höllriegel R; Desch S; Thiele H; Lurz P
    Circulation; 2019 Jan; 139(5):590-600. PubMed ID: 30586691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience.
    Fengler K; Höllriegel R; Okon T; Stiermaier T; Rommel KP; Blazek S; Besler C; von Roeder M; Petzold M; Schuler G; Lurz P
    J Hypertens; 2017 Jun; 35(6):1310-1317. PubMed ID: 28441700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Ewen S; Dörr O; Ukena C; Linz D; Cremers B; Laufs U; Hamm C; Nef H; Bauer A; Mancia G; Böhm M; Mahfoud F
    J Hypertens; 2015 Dec; 33(12):2512-8. PubMed ID: 26485461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraprocedural reduction of the veno-arterial norepinephrine gradient correlates with blood pressure response after renal denervation.
    Tiroch K; Sause A; Szymanski J; Nover I; Leischik R; Mann JF; Vorpahl M; Seyfarth M
    EuroIntervention; 2015 Nov; 11(7):824-34. PubMed ID: 26603990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements.
    Vogt A; Dutzmann J; Nußbaum M; Hoyer D; Tongers J; Schlitt A; Sedding D; Plehn A
    Front Cardiovasc Med; 2023; 10():1210801. PubMed ID: 37404730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter-based radiofrequency renal sympathetic denervation for resistant hypertension.
    Damascelli B; Patelli G; Tichá V; Della Rocca F; Lattuada S; Sala C; Albertoni A; D'Alessio A; Funaro A; Scotti L
    J Vasc Interv Radiol; 2013 May; 24(5):632-9. PubMed ID: 23622036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H; Schofer J; Ormiston J; Hoppe UC; Meredith IT; Walters DL; Azizi M; Diaz-Cartelle J; Cohen-Mazor M
    EuroIntervention; 2015 Feb; 10(10):1213-20. PubMed ID: 25452197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A; Ditting T; Sobotka PA; Veelken R; Schmieder RE; Uder M; Ott C
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):987-91. PubMed ID: 23771326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience.
    Ott C; Schmid A; Ditting T; Veelken R; Uder M; Schmieder RE
    Clin Exp Nephrol; 2019 Jun; 23(6):749-755. PubMed ID: 30783914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sympathetic denervation for treatment of resistant hypertension: Egyptian experience.
    Hamza M; Khamis H
    J Interv Cardiol; 2014 Aug; 27(4):423-7. PubMed ID: 25041156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.